» Articles » PMID: 34021347

Tracheobronchial Stents in Patients with Malignant Airway Disease: Finnish Tertiary Care Experience

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Tracheobronchial stenting has an established role in the palliation of malignant central airway obstruction (CAO). The purpose of this study is to describe the experience with self-expanding metal airway stents in 2 tertiary referral centres, covering a third of the population of Finland.

Methods: Patients referred to and treated with airway stenting for malignant CAO using self-expanding metal-stents were identified from electronic patient records, and data were collected using a structured Endoscopic Lower Airway Management instrument. Statistical analysis to reveal factors affecting patient benefit and survival was carried out.

Results: A total of 101 patients (mean age 65.8) and 116 procedures were identified. Procedure-related mortality was rare (3/101 patients) and complications infrequent. The median survival was 2.3 months [95% confidence interval (CI): 1.4-3.1). Stent benefit was not significantly affected by clinical characteristics. Survival was impacted by the use of adjunct procedures [hazard ratio (HR) 0.36, 95% CI: 0.23-0.58, P < 0.001), procedural urgency (HR 0.40; 95% CI: 0.23-0.71, P = 0.002) and post-treatment chemoradiotherapy (HR 0.29, 95% CI: 0.15-0.56, P < 0.001).

Conclusions: The beneficial impact observed supports the further use of tracheobronchial stenting in malignant CAO. The use of self-expanding metal stents is encouraged.

Citing Articles

Patient-centred outcome following endoscopic management of benign central airway obstruction.

Bogh M, Larsen D, Lonka M, Schytte S, Pedersen U, Gade S Eur Arch Otorhinolaryngol. 2025; .

PMID: 39979626 DOI: 10.1007/s00405-025-09230-1.


Palliative endoscopic treatment of malignant central airway obstruction.

Bogh M, Heinonen S, Larsen D, Gade S, Schytte S, Pedersen U BMC Pulm Med. 2024; 24(1):635.

PMID: 39734226 PMC: 11684241. DOI: 10.1186/s12890-024-03432-9.


Predictors in the treatment of malignant central airway obstruction with silicone stents.

Bogh M, Gade S, Larsen D, Schytte S, Pedersen U, Kjaergaard T Eur Arch Otorhinolaryngol. 2024; 281(3):1457-1462.

PMID: 38183453 PMC: 10858089. DOI: 10.1007/s00405-023-08365-3.

References
1.
Menna C, Poggi C, Ibrahim M, DAndrilli A, Ciccone A, Maurizi G . Coated expandable metal stents are effective irrespective of airway pathology. J Thorac Dis. 2017; 9(11):4574-4583. PMC: 5720987. DOI: 10.21037/jtd.2017.10.139. View

2.
Wood D, Liu Y, Vallieres E, Karmy-Jones R, Mulligan M . Airway stenting for malignant and benign tracheobronchial stenosis. Ann Thorac Surg. 2003; 76(1):167-72; discussion 173-4. DOI: 10.1016/s0003-4975(03)00033-x. View

3.
Guibert N, Mazieres J, Lepage B, Plat G, Didier A, Hermant C . Prognostic factors associated with interventional bronchoscopy in lung cancer. Ann Thorac Surg. 2013; 97(1):253-9. DOI: 10.1016/j.athoracsur.2013.07.118. View

4.
Amjadi K, Voduc N, Cruysberghs Y, Lemmens R, Fergusson D, Doucette S . Impact of interventional bronchoscopy on quality of life in malignant airway obstruction. Respiration. 2008; 76(4):421-8. DOI: 10.1159/000152832. View

5.
Wilson G, Walshaw M, Hind C . Treatment of large airway obstruction in lung cancer using expandable metal stents inserted under direct vision via the fibreoptic bronchoscope. Thorax. 1996; 51(3):248-52. PMC: 1090633. DOI: 10.1136/thx.51.3.248. View